Shanghai Labway Clinical Laboratory Co. Ltd. proposed final cash dividend/10 shares (tax included) of CNY 3.00000000 for the year 2022.
Shanghai Labway Clinical Laboratory Co., Ltd
Equities
301060
CNE100004RG8
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.48 CNY | -2.78% | -1.23% | -21.14% |
1st Jan change | Capi. | |
---|---|---|
-21.14% | 579M | |
-13.90% | 8.58B | |
+60.25% | 4.12B | |
-43.01% | 2.29B | |
-10.51% | 2.44B | |
-3.13% | 2.48B | |
-3.40% | 2B | |
-19.79% | 1.53B | |
-40.57% | 1.21B | |
+9.11% | 1.12B |
- Stock Market
- Equities
- 301060 Stock
- News Shanghai Labway Clinical Laboratory Co., Ltd
- Shanghai Labway Clinical Laboratory Co., Ltd Proposes Final Cash Dividend for the Year 2022